Pfizer
Tony Blair's Covid grift
Have we yet seen the end of Covid restrictions? It is tempting to think so. For many people, Covid and…
Pfizer’s Covid pill breakthrough
After the UK medicines regulator yesterday approved Merck’s Covid pill for use on recently infected, vulnerable patients, Pfizer announced its…
Why Israel is rolling out a third Covid jab
Israel has today become the first country in the world to offer a third Covid-19 booster vaccine on a large…
Should we be mixing AstraZeneca and Pfizer shots?
To date, the Covid vaccination programme in Britain has involved two doses of one of three vaccines – AstraZeneca, Pfizer…
Should we mix Pfizer and AstraZeneca Covid jabs?
Should the NHS be mixing vaccines for better effect, or at least offering people who have had one dose of…
Merkel is right to reject Biden's vaccine patent plan
She handed the vaccine procurement process over to the European Union. She didn’t invest much in new production. And she…
How much of a threat is the South African variant?
For residents of six London boroughs, as well as those in Smethwick in the West Midlands, the partial relaxation of…
How effective are the Covid vaccines?
Reports have filtered through this morning about Public Health England’s assessment of the efficacy of the two vaccines so far…
Can we boost immunity with the vaccines we have now?
What to make of the news this morning that Oxford University is to ask for volunteers to take part in…
How Israel became a world leader in vaccination
On a cold night three days before the end of the 2020 I drove down to Jerusalem’s Pais Arena. The…
Europe’s slow vaccine approval is testing Germany’s patience
The Bundestag can’t be an easy place to be a politician right now. At the start of the pandemic, Germany…
Don't panic about the Covid vaccine allergy risk
In the coming weeks, you are inevitably going to see a slew of stories in the media about side effects…
Did Brexit lead to the UK’s vaccine success?
Today the United Kingdom became the first country in the West to clinically authorise a vaccine protecting against Covid-19, after…
There's nothing wrong with profiting from a vaccine
A couple of shots to the arm and this will all be over. With today’s news from Moderna, last week’s…
The questions we must ask about the Covid vaccine
The Covid vaccine still has a long way to go
Pfizer U-turns at warp speed
Pfizer announced Monday that a coronavirus vaccine the company was working on had proven to be 90 percent effective at…
Will the Pfizer vaccine live up to the hype?
So is this the big turning point? Markets certainly seem to think so. No sooner had news broken that the…
We must play the blame game over HBOS. How else will bankers learn?
‘Everyone remembers the names of Applegarth of Northern Rock and Goodwin of RBS, but history may judge the HBOS men…
Why I’m thankful that Atos found me fit to work
Being found ‘fit for work’ changed my life for the better
George Osborne’s cynical grab for northern votes (and why I’m for it)
When John Prescott used to wax garrulous about a ‘superhighway’ from Hull to Liverpool, everyone assumed it was a wheeze…
Forget about saving British big pharma – it's little pharma we should be helping
Readers in all sorts of places — at the club bar, over a birthday lunch, even along the church pew…
Pfizer’s already beaten Ed Miliband. Now it just needs to offer the right price
Pfizer will almost certainly have to offer more than its second bid of £50 a share for rival drug giant…
Portrait of the week
Home The British economy grew by 0.8 per cent in the first quarter of 2014, disappointing hotheads who’d expected 1 per cent. It…
Why the bankers’ bonus debate is not going away
A bouquet to Alison Kennedy, ‘governance and stewardship director’ at the Edinburgh-based pensions provider Standard Life, for leading the rebellion…
